Key facts
- It has raised $3.0M across 5 recorded rounds; the latest was Seed Round ($1.2M) in Dec 2022.
- Cx Precision Medicine has filed 5 Form Ds with the SEC since 2016, most recently Jun 2024 ( sold).
Free account
See the evidence behind this price
- ·Post-money valuations for all 5 rounds
- ·Watchlist + deal alerts for Cx Precision Medicine
Create free account
No card required
Funding rounds
5 roundsJan 2022Accelerator/Incubator—▮
About Cx Precision Medicine
- Industry
- Other Pharmaceuticals and Biotechnology
PA Mark — not yet priced
Cx Precision Medicine doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Pro members can request priority coverage with a 48-hour turnaround.
Recorded secondary trades
No prints on record
No secondary trades in Cx Precision Medicine shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Pro members can request priority coverage with a 48-hour turnaround.
Institutional fund marks
No fund marks yet
No SEC-registered fund has reported a fair-value mark on Cx Precision Medicine in its N-PORT filings yet. We sweep new filings monthly.
Pro members can request priority coverage with a 48-hour turnaround.